BTC $62,730.04 -1.17%
ETH $1,872.83 -0.43%
BNB $604.29 -0.73%
XRP $1.00 -0.30%
SOL $75.34 -0.54%
TRX $0.3328 -0.24%
DOGE $0.0693 -1.07%
ADA $0.1797 -1.95%
BCH $205.12 -3.79%
LINK $8.81 +1.12%
HYPE $56.05 -1.93%
AAVE $85.88 -3.12%
SUI $0.6736 -1.84%
XLM $0.1585 -0.78%
ZEC $484.08 -1.39%
BTC $62,730.04 -1.17%
ETH $1,872.83 -0.43%
BNB $604.29 -0.73%
XRP $1.00 -0.30%
SOL $75.34 -0.54%
TRX $0.3328 -0.24%
DOGE $0.0693 -1.07%
ADA $0.1797 -1.95%
BCH $205.12 -3.79%
LINK $8.81 +1.12%
HYPE $56.05 -1.93%
AAVE $85.88 -3.12%
SUI $0.6736 -1.84%
XLM $0.1585 -0.78%
ZEC $484.08 -1.39%

The publicly traded company Applied DNA Sciences disclosed that its initial BNB holdings are valued at over 17 million dollars

2025-10-22 20:20:58

ChainCatcher news, according to businesswire, biotechnology company Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has completed the previously announced private equity investment (PIPE) financing led by institutional DeFi and TradFi investors, with an initial BNB holding valued at over $17 million.

The PIPE brought the company approximately $27 million in total proceeds, with the potential to gain an additional total of up to $31 million in the future through the exercise of warrants. The total proceeds from the PIPE transaction include $15.3 million in cash and stablecoins, as well as $11.71 million in OBNB trust units.

The company has received a total of 435,638 trust units, which represent underlying ownership of 10,647 BNB tokens. The company also announced today that it has additionally purchased 4,908 BNB tokens, estimated to be worth $5.3 million as of 10:00 PM Eastern Time on October 20, 2025.

app_icon
ChainCatcher Building the Web3 world with innovations.